Dan O’Leary made a presentation at the FDA’s Laboratory Developed Test (LDT). The slides are on the Ombu Website in the Library section.
Ombu took the position that regardless of the source of the test (IVD test kit or Laboratory Developed Test) the regulatory requirements should be the same; the level playing field argument.